Brillient BPA for subject matter expert and technical expert strategic planning services.
Ended Awarded Last action
- Contract number
- 75F40121F19182
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $235,630
Award facts
- Contract value 100% obligated
- $235,630.15 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$12,253 | |
| Other Administrative Action | $29,985 | |
| Other Administrative Action | $2,500 | |
| Exercise an Option | $114,418 | |
| Original award | $100,980 |
About this award
This is a Blanket Purchase Agreement (BPA) call awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Brillient Corporation, a minority-owned, for-profit Subchapter S Corporation. The contract is for subject matter expert and technical expert strategic planning services, with a potential value of $235,630.15 and a completion date of August 4, 2023. This BPA call was issued under the Multiple Award Schedule (MAS) contract vehicle, which is a General Services Administration (GSA) program that allows federal agencies to procure a wide range of commercial services and products. Brillient Corporation has been awarded numerous federal contracts from various agencies, including HHS, for services such as IT, engineering, consulting, and administrative support.
Quick answers
Who was awarded contract 75F40121F19182?
75F40121F19182 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on August 5, 2021.
How much is contract 75F40121F19182 worth?
The government has obligated $235,630 on 75F40121F19182.
Is contract 75F40121F19182 an order under another contract?
Yes. 75F40121F19182 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40121F19182 competed?
The extent of competition for 75F40121F19182 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award